Formulation Development White Papers & Articles
-
Analytical Tools To Address The Development Of GLP-1 Receptor Agonists
9/2/2025
GLP-1 receptor agonists are revolutionizing therapeutics beyond diabetes. Explore analytical innovations that ensure safety and efficacy as these peptides expand into multiple treatments.
-
Navigating The Regulatory Space To Biosimilar Approval
9/1/2025
The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.
-
Aggregation In Antibody-Drug Conjugates: Causes And Mitigation
9/1/2025
Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.
-
Enhancing Throughput And Reproducibility In Proteomic Analysis
8/27/2025
Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.
-
Streamlining Cell Line Development For Antibodies
8/27/2025
Streamline your antibody production with a robust Cell Line Development strategy. Discover how automation, analytics, and digital tools accelerate development from clone selection to commercialization.
-
Improving The Efficiency And Quality Of Advanced Imaging And Analysis
8/27/2025
Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.
-
Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection
8/27/2025
The growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.
-
3D Biology And Spatial Profiling: Expert Insights
8/27/2025
Human-relevant models and spatial profiling are transforming drug discovery. Explore how predictive, human-like insights improve disease modeling, drug screening, and personalized treatment development.
-
Time To Intensify: Taking mAb Manufacturing To The Next Level
8/19/2025
Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results.
-
Streamline Drug Development With A Lab Informatics Platform
8/13/2025
Learn how a tiered approach to ADME-Tox studies can help researchers navigate early-stage preclinical research and mitigate the risk of costly failures in drug development.